Previous Close | 38.54 |
Open | 38.65 |
Bid | 30.25 x 900 |
Ask | 0.00 x 900 |
Day's Range | 38.52 - 39.31 |
52 Week Range | 19.14 - 44.40 |
Volume | |
Avg. Volume | 299,473 |
Market Cap | 1.923B |
Beta (5Y Monthly) | 0.98 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -3.62 |
Earnings Date | Feb 06, 2023 - Feb 10, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Nov 30, 2016 |
1y Target Est | 43.33 |
Adtalem (ATGE) delivered earnings and revenue surprises of 31.46% and 2.48%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
CHICAGO, February 02, 2023--Adtalem Global Education Inc. (NYSE: ATGE), a national leader in post-secondary education and a leading provider of professional talent to the healthcare industry, today reported academic, operating, and financial results for its second quarter fiscal 2023 ended Dec. 31, 2022. The earnings press release and a presentation used to accompany the webcast are accessible by visiting the Investor Relations section of Adtalem’s website, located at the following link: https:/
Adtalem's (ATGE) fiscal Q2 earnings are likely to have been aided by cost synergies and operational efficiencies, despite industry-related risks.